Alzheimer’s Insights Summit 4: From AI to Impact

The fourth Alzheimer’s Insights Summit comes to Boston on the opening day of CTAD 2026. Under the theme “From AI to Impact: Accelerating Alzheimer’s Discovery, Trials and Care”, this half-day summit brings together researchers, clinicians, data scientists, funders and industry to look at how artificial intelligence is moving from promise into practice across Alzheimer’s research.

The summit is co-hosted by the Alzheimer’s Disease Data Initiative (AD Data Initiative), StartUp Health, the Clinical Trial Recruitment Lab at the USC Schaeffer Center, and the Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (ADDF DxA).

It runs from 11am to 3pm (Eastern Time) on Monday 16 November 2026 at the Sheraton Boston Hotel, the same day the Clinical Trials on Alzheimer’s Disease (CTAD) conference opens in the city, so it is well placed for anyone already travelling to CTAD.

The series runs alongside major Alzheimer’s meetings. The previous summit was held at AD/PD in Copenhagen in March 2026, where finalists pitched for the $1 million Alzheimer’s Insights AI Prize.

Registration

Pre-registration is required. The form asks for your job title and organisational affiliation, and any dietary requirements. Registering also gives the AD Data Initiative permission to photograph and record attendees at the event, and to email you about it.

Register for the Alzheimer’s Insights Summit 4